Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Athlone Pharmaceuticals Limited, Ballymurray, Co. Roscommon, Ireland
For the treatment of thiamine deficiencies due to increased dietary requirements, reduced intakes, reduced absorption or increased excretion. Also for treatment of Wernicke-Korsakoff syndrome, beriberi and thiamine deficiency related to chronic alcoholism.
Situations often accompanied by marginal thiamine deficiency and requiring supplementation include but are not limited to:
Mild deficiency: 50-100mg per day.
Severe deficiency: 200-300mg per day in divided doses.
Not recommended for children under 12 years.
Oral.
Overdose with this route of administration is unlikely. A suspected overdose should be treated symptomatically.
Blister: 2 years.
Pot: 2 years – unopened.
After first opening the pot, medicinal product should be used within 100 days.
Store below 25°C.
Store in the original package.
For storage conditions after first opening of pots, see section 6.3.
Pot: Polypropylene snap Secure Pot with HDPE/LDPE closure.
Blister pack: 250μm PVC/PVDC (white opaque) with 40 gsm aluminium foil (20μm).
84 tablets in blisters and 100 tablets in pots packaging.
Not all pack sizes may be marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
